AI Summary
This grant opportunity (PAR-25-026) from the NHLBI supports early phase clinical trials for therapeutics and/or diagnostics for Heart, Lung, Blood, and Sleep (HLBS) disorders. It utilizes an R61/R33 phased award mechanism and requires a clinical trial.